HopeStage
Back to all studies
RecruitingNCT07363551

Omega-3 supplements, inflammation and gut microbes in youth with depression

About this titleRead the official source — NCT07363551
Placebo comparisonAges 13–18Taiwan
The study in practice

Understand this study

Who could participate?

Listed age limits: 13 years to 18 years.

Listed locations
TaichungSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 9, 2021
Recruitment status
Recruiting
Enrollment listed in the registry
60
Sponsor
China Medical University Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Combination product, Dietary supplement
Locations
Taiwan
Age range
From 13 Years to 18 Years
Official registry ID
NCT07363551
Official title
Show the full official title

Omega-3 Fatty Acids, Inflammation, Gut Microbiota in Youth With Depression (OMIMYDep)- A Double-blind Randomized Controlled Trial

Recruitment & locations

Currently recruiting

Taichung

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is China Medical University Hospital, a hospital or academic medical center.

Who can participate?

Listed age limits: 13 years to 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies